Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.210 EUR
−10.67 M EUR
0.00 EUR
46.48 M
About MediciNova, Inc.
Sector
Industry
CEO
Yuichi Iwaki
Website
Headquarters
La Jolla
Founded
2000
FIGI
BBG004LZGZ96
MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.
Related stocks
Vaccine Joint Development with BioComo and Mie University JapanMediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan
through our joint development with MediciNova, we will proceed with further non-clinical and clinical trial development as quickly as possible globally and not only in Japan.
We are confident that the B
$MNOV can rise in the next daysContextual immersion trading strategy idea.
The demand for shares of MediciNova looks higher than the supply.
The company focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs.
Due to the spread of COVID-19, the demand for the c
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange MEDICINOVA NEW DL-,001 stocks are traded under the ticker RMN.
We've gathered analysts' opinions on MEDICINOVA NEW DL-,001 future price: according to them, RMN price has a max estimate of 7.80 EUR and a min estimate of 4.33 EUR. Watch RMN chart and read a more detailed MEDICINOVA NEW DL-,001 stock forecast: see what analysts think of MEDICINOVA NEW DL-,001 and suggest that you do with its stocks.
Yes, you can track MEDICINOVA NEW DL-,001 financials in yearly and quarterly reports right on TradingView.
MEDICINOVA NEW DL-,001 is going to release the next earnings report on Aug 8, 2025. Keep track of upcoming events with our Earnings Calendar.
RMN earnings for the last quarter are −0.06 EUR per share, whereas the estimation was −0.13 EUR resulting in a 57.14% surprise. The estimated earnings for the next quarter are −0.08 EUR per share. See more details about MEDICINOVA NEW DL-,001 earnings.
RMN net income for the last quarter is −2.65 M EUR, while the quarter before that showed −2.72 M EUR of net income which accounts for 2.63% change. Track more MEDICINOVA NEW DL-,001 financial stats to get the full picture.
No, RMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 22, 2025, the company has 13 employees. See our rating of the largest employees — is MEDICINOVA NEW DL-,001 on this list?
Like other stocks, RMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDICINOVA NEW DL-,001 stock right from TradingView charts — choose your broker and connect to your account.